Marshall Wace
AVNS

Marshall Wace’s Avanos Medical AVNS Stock Holding History

Marshall Wace’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.81M Buy
+354,231
New +$8.29M 0.01% 1092
2026
Q1 		– Sell
-68,109
Closed -$765K – 3188
2025
Q4 		$765K Buy
+68,109
New +$779K ﹤0.01% 2062
2025
Q2 		– Sell
-39,341
Closed -$564K – 2697
2025
Q1 		$564K Sell
39,341
-25,424
-39% -$397K ﹤0.01% 2031
2024
Q4 		$1.03M Buy
+64,765
New +$1.28M ﹤0.01% 1721
2023
Q3 		– Sell
-20,100
Closed -$514K – 2181
2023
Q2 		$514K Sell
20,100
-2,200
-10% -$57.9K ﹤0.01% 1970
2023
Q1 		$663K Buy
+22,300
New +$647K ﹤0.01% 1988
2022
Q2 		– Sell
-253,525
Closed -$8.49M – 3405
2022
Q1 		$8.49M Buy
253,525
+220,924
+678% +$7.11M 0.02% 988
2021
Q4 		$1.13M Buy
32,601
+1,160
+4% +$37.5K ﹤0.01% 2417
2021
Q3 		$981K Buy
+31,441
New +$1.07M ﹤0.01% 2030
2021
Q2 		– Sell
-48,785
Closed -$2.13M – 2638
2021
Q1 		$2.13M Buy
+48,785
New +$2.29M 0.01% 1297
2020
Q4 		– Sell
-57,024
Closed -$1.89M – 1869
2020
Q3 		$1.89M Sell
57,024
-79,448
-58% -$2.54M 0.01% 825
2020
Q2 		$4.01M Buy
136,472
+65,278
+92% +$1.89M 0.03% 550
2020
Q1 		$1.92M Buy
+71,194
New +$2.13M 0.02% 646
2019
Q4 		– Sell
-33,280
Closed -$1.25M – 1685
2019
Q3 		$1.25M Sell
33,280
-137,784
-81% -$5.26M 0.01% 885
2019
Q2 		$7.46M Buy
171,064
+126,969
+288% +$5.43M 0.06% 367
2019
Q1 		$1.88M Sell
44,095
-111,742
-72% -$5M 0.02% 757
2018
Q4 		$6.98M Buy
155,837
+81,786
+110% +$4.28M 0.07% 348
2018
Q3 		$5.07M Buy
+74,051
New +$4.77M 0.04% 455
2015
Q4 		– Sell
-25,699
Closed -$731K – 968
2015
Q3 		$731K Sell
25,699
-1,097
-4% -$38.3K 0.01% 673
2015
Q2 		$1.08M Hold
26,796
– – 0.01% 590
2015
Q1 		$1.32M Sell
26,796
-241,157
-90% -$11.2M 0.02% 532
2014
Q4 		$12.2M Buy
+267,953
New +$10.5M 0.16% 164

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Marshall Wace's AVNS Position: Q2 2026 in Review

Marshall Wace opened a new position in Avanos Medical (AVNS) in Q2 2026: 354,231 shares worth $8.81M. The stake represents 0.01% of the portfolio and ranks #1092 among its holdings. This is a return to the name: Marshall Wace previously reported a position in AVNS as recently as Q4 2025.

Marshall Wace first reported a position in AVNS in Q4 2014 and has held it in 22 quarters since. The position peaked at $12.2M in Q4 2014. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Marshall Wace held 354,231 shares of Avanos Medical worth $8.81M as of Q2 2026.
  • Avanos Medical was a new Marshall Wace position in Q2 2026.
  • Avanos Medical made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #1092 holding.
  • Marshall Wace first reported a position in Avanos Medical in Q4 2014 and has held it in 22 quarters since.
  • Marshall Wace's Avanos Medical position peaked at $12.2M in Q4 2014.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.